Yellow Card Biobank - Home Blood Sample Collection

The Medicines and Healthcare products Regulatory Agency (MHRA) is the executive Agency of the Department of Health and Social Care that acts on behalf of the Ministers to protect and promote public health and patient safety, by ensuring that healthcare products meet appropriate standards of safety, quality and efficacy.

The Patient Safety Monitoring function conducts market surveillance and signal detection of potential product safety issues and patient concerns to respond proactively and appropriately, keeping patients safe and healthy.

The MHRA is committed to completing a two-year Yellow Card biobank pilot. To facilitate the pilot, a nursing organisation is required to supply phlebotomists to carry out biological sample collection services from up to 250 eligible participants (at their home) across the UK between February 2024 and March 2025.